Yvon Camille, Patel Bhupendra, Ng John, Altman Marcus T, Malhotra Raman
Corneoplastic Unit, Queen Victoria Hospital NHS Trust, East Grinstead, Sussex, United Kingdom.
Moran Eye Center, University of Utah, Salt Lake City, UT, USA.
J Ophthalmic Vis Res. 2024 Jun 21;19(2):235-245. doi: 10.18502/jovr.v19i2.10908. eCollection 2024 Apr-Jun.
To investigate oculoplastic conditions in patients diagnosed with coronavirus disease 2019 (COVID-19) seen at ophthalmology departments of three tertiary referral centers in the United Kingdom and the United States, and review of the literature.
Retrospective multicenter case series studied over 18 months.
A total of four patients developed eyelid, orbital, or lacrimal gland pathology within four weeks of testing positive for COVID-19. All were male, and the mean age at presentation was 49 (range, 31-58 years). Suspected diagnoses included anterior idiopathic orbital inflammation, facial angioedema, dacryoadenitis, and anophthalmic socket inflammation. Three patients recovered fully and one patient recovered partially (mean 2.7 weeks) from ocular manifestations with steroids hastening recovery.
Adnexal manifestations of COVID-19 include self-limiting orbital inflammation and eyelid lymphedema.
调查在英国和美国三个三级转诊中心眼科就诊的2019冠状病毒病(COVID-19)确诊患者的眼部整形情况,并进行文献综述。
回顾性多中心病例系列研究,为期18个月。
共有4例患者在COVID-19检测呈阳性后的4周内出现眼睑、眼眶或泪腺病变。所有患者均为男性,就诊时的平均年龄为49岁(范围31 - 58岁)。疑似诊断包括前部特发性眼眶炎症、面部血管性水肿、泪腺炎和无眼球眼眶炎症。3例患者完全康复,1例患者眼部表现部分恢复(平均2.7周),类固醇药物加速了恢复。
COVID-19的附属器表现包括自限性眼眶炎症和眼睑淋巴水肿。